MedTrace Logo

Research Study for Rare Pathogenic Mutations Causing Type 2 Diabetes and Complications

NCT04700813 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2021-01-08

No results posted yet for this study

Summary

Single-center trial The goal is to better understand the various genetic mutations encountered in cases of type 2 diabetes as well as their frequency of occurrence in the population.

Such analyzes also make it possible to develop personalized medicine and to be able to prevent the associated risks.

The aim of this work is also to demonstrate the value of a systematic genetic diagnosis of patients with DMT2 in order to improve their clinical management.

Taking a blood sample, which will consist of the single sample from the entire study (1 single visit, combined with a follow-up visit to the patient's usual diabetist).

Participation in this study would make it possible to diagnose rare pathogenic mutations in type 2 diabetes and therefore to be able to adapt the treatment in a specific and personal way depending on the presence or not of the mutations and also to prevent the appearance of other pathologies.

Conditions

  • Diabete Type 2

Interventions

DIAGNOSTIC_TEST

search for rare pathogenic mutations

search for rare pathogenic mutations causing diabetes type 2

Sponsors & Collaborators

  • EGID, Lille

    collaborator UNKNOWN

  • University of Liege

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-13
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04700813 on ClinicalTrials.gov